Clinical and genetic determinants of plasma nevirapine exposure following an intrapartum dose to prevent mother-to-child HIV transmission.

Vardhanabhuti S, Acosta EP, Ribaudo HJ, Severe P, Lalloo U, Kumarasamy N, Taulo F, Kabanda J, Oneko O, Ive P, Sambarey P, Chan ES, Hitti J, Hong F, McMahon D, Haas DW, A5207 ACTG Study Team
J Infect Dis. 2013 208 (4): 662-71

PMID: 23687222 · PMCID: PMC3719905 · DOI:10.1093/infdis/jit223

MeSH Terms (20)

Adult Anti-HIV Agents Aryl Hydrocarbon Hydroxylases Chemoprevention Cytochrome P-450 CYP2B6 Female HIV Infections Humans Infant, Newborn Infectious Disease Transmission, Vertical Inhibitory Concentration 50 Male Metabolic Clearance Rate Nevirapine Oxidoreductases, N-Demethylating Plasma Polymorphism, Genetic Pregnancy Time Factors Young Adult

Connections (1)

This publication is referenced by other Labnodes entities: